Evidence map›Paper›PMID 25471565›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

Melissa E Murray, Scott A Przybelski, Timothy G Lesnick, Amanda M Liesinger, Anthony Spychalla, Bing Zhang, Jeffrey L Gunter, Joseph E Parisi, Bradley F Boeve, David S Knopman and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Intranasal Administration of Isoeugenol Improves Memory Deficits in APP/PS1 Old Mice-A Role Beyond Nrf2 Activation?FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Article
  7. Neurobiology of aging · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Review
  15. Comparison of multiple quantitative strategies for neuropathologic image analyses.Journal of neuropathology and experimental neurology · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Melissa E MurrayDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, and.ORCID http://orcid.org/0000-0001-7379-2545
Scott A PrzybelskiDepartment of Biomedical Statistics.
Timothy G LesnickDepartment of Biomedical Statistics.
Amanda M LiesingerDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, and.
Anthony SpychallaDepartment of Radiology.
Bing ZhangDepartment of Radiology.
Jeffrey L GunterDepartment of Radiology.
Joseph E ParisiDepartment of Pathology, and.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, Minnesota 55905.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, Minnesota 55905.ORCID http://orcid.org/0000-0002-6544-066X
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, Minnesota 55905.
Clifford R JackDepartment of Radiology.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, and.
Kejal KantarciDepartment of Radiology, kantarci.kejal@mayo.edu.
Jacksonville College · USMayo Clinic · USMayo Clinic in Florida · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5U01HL096917 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI MOSLEY, THOMAS H · 2010 to 2018
$11.9M
Genetic Consortium for Late Onset Alzheimer's DiseaseU24AG026395 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P · 2005 to 2009
$10.1M
Neuropathology CoreP50NS072187 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 2010 to 2017
$8.7M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
Imaging CoreU01AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2008 to 2009
$6.1M
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease PatientsR01AG037551 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI MURRAY, ANNE M · 2011 to 2015
$2.7M
NEUROPSYCHOLOGY OF DEMENTIA WITH LEWY BODIESR01AG015866 · NIA · MAYO CLINIC JACKSONVILLE · PI FERMAN, TANIS JILL · 1999 to 2009
$2.6M
NHLBI NIH HHS U01 HL096917NIA NIH HHS P50 AG016574NIA NIH HHS P50-AG016574/P1NIA NIH HHS P50 AG044170NIA NIH HHS R01 AG011378NIA NIH HHS R01-AG011378NIA NIH HHS R01 AG015866NIA NIH HHS R01 AG037551NIA NIH HHS R01 AG040042NIA NIH HHS R01-AG040042NIA NIH HHS R01 AG041851NIA NIH HHS U01 AG006786NIA NIH HHS U01-AG006786NIA NIH HHS U01 AG024904NIA NIH HHS U01 AG032438NIA NIH HHS U24 AG026395NINDS NIH HHS P50 NS072187
6 · The paper itself

Abstract

Proton magnetic resonance spectroscopy ((1)H-MRS) is sensitive to early neurodegenerative processes associated with Alzheimer's disease (AD). Although (1)H-MRS metabolite ratios of N-acetyl aspartate (NAA)/creatine (Cr), NAA/myoinositol (mI), and mI/Cr measured in the posterior cingulate gyrus reveal evidence of disease progression in AD, pathologic underpinnings of the (1)H-MRS metabolite changes in AD are unknown. Pathologically diagnosed human cases ranging from no likelihood to high likelihood AD (n = 41, 16 females and 25 males) who underwent antemortem (1)H-MRS of the posterior cingulate gyrus at 3 tesla were included in this study. Immunohistochemical evaluation was performed on the posterior cingulate gyrus using antibodies to synaptic vesicles, hyperphosphorylated tau (pTau), neurofibrillary tangle conformational-epitope (cNFT), amyloid-β, astrocytes, and microglia. The slides were digitally analyzed using Aperio software, which allows neuropathologic quantification in the posterior cingulate gray matter. MRS and pathology associations were adjusted for time from scan to death. Significant associations across AD and control subjects were found between reduced synaptic immunoreactivity and both NAA/Cr and NAA/mI in the posterior cingulate gyrus. Higher pTau burden was associated with lower NAA/Cr and NAA/mI. Higher amyloid-β burden was associated with elevated mI/Cr and lower NAA/mI ratios, but not with NAA/Cr. (1)H-MRS metabolite levels reveal early neurodegenerative changes associated with AD pathology. Our findings support the hypothesis that a decrease in NAA/Cr is associated with loss of synapses and early pTau pathology, but not with amyloid-β or later accumulation of cNFT pathology in the posterior cingulate gyrus. In addition, elevation of mI/Cr is associated with the occurrence of amyloid-β plaques in AD.

Indexed as

Proton Magnetic Resonance SpectroscopyAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesAspartic AcidAstrocytesBiomarkersCase-Control StudiesEarly DiagnosisFemaleFunctional NeuroimagingGray MatterGyrus CinguliHumansInositolMaleAmyloid beta-PeptidesAspartic AcidBiomarkersInositolN-acetylaspartatetau ProteinsAlzheimer's diseasedigital microscopymagnetic resonance spectroscopyneuropathologyposterior cingulatetau

Identifiers

PMID25471565
PMCPMC4252542
OpenAlexW2054163710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.